Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission

Manasa S. Reddy, Sandra Hofmann, Yu Min Shen, Srikanth Nagalla, Siayareh Rambally, Amena Usmani, Ravi Sarode

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission'. Together they form a unique fingerprint.

Medicine & Life Sciences